AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,664,621 | -4.7% | 219,130 | -1.5% | 0.01% | -11.1% |
Q2 2023 | $2,794,650 | -21.3% | 222,504 | -23.5% | 0.01% | -30.8% |
Q4 2022 | $3,549,838 | +223.6% | 290,732 | +176.6% | 0.01% | +160.0% |
Q3 2022 | $1,097,000 | +459.7% | 105,097 | +475.2% | 0.01% | +400.0% |
Q2 2022 | $196,000 | -96.0% | 18,272 | -91.5% | 0.00% | -95.5% |
Q4 2020 | $4,935,000 | -31.5% | 213,720 | -58.1% | 0.02% | -21.4% |
Q3 2020 | $7,201,000 | -8.7% | 509,946 | -2.5% | 0.03% | -30.0% |
Q2 2020 | $7,884,000 | +264.7% | 522,844 | +123.5% | 0.04% | +185.7% |
Q1 2020 | $2,162,000 | -23.5% | 233,964 | -19.4% | 0.01% | +55.6% |
Q4 2019 | $2,826,000 | +30.7% | 290,098 | +7.6% | 0.01% | +12.5% |
Q3 2019 | $2,163,000 | -40.5% | 269,697 | -7.4% | 0.01% | -38.5% |
Q2 2019 | $3,636,000 | +97.7% | 291,361 | +115.5% | 0.01% | +85.7% |
Q1 2019 | $1,839,000 | +30.7% | 135,185 | -8.0% | 0.01% | +16.7% |
Q4 2018 | $1,407,000 | -46.8% | 146,900 | -32.9% | 0.01% | -40.0% |
Q3 2018 | $2,645,000 | +340.8% | 218,786 | +469.2% | 0.01% | +400.0% |
Q2 2018 | $600,000 | -85.6% | 38,435 | -86.2% | 0.00% | -89.5% |
Q1 2018 | $4,177,000 | – | 277,678 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 22,790,134 | $182,777,000 | 6.12% |
Perceptive Advisors | 24,609,700 | $197,369,000 | 5.32% |
SECTORAL ASSET MANAGEMENT INC | 3,441,922 | $27,604,000 | 4.76% |
Palo Alto Investors LP | 7,162,920 | $57,447,000 | 3.83% |
Avoro Capital Advisors LLC | 11,100,000 | $89,022,000 | 3.71% |
SPHERA FUNDS MANAGEMENT LTD. | 2,930,320 | $23,501,000 | 3.63% |
Ghost Tree Capital, LLC | 1,705,000 | $13,674,000 | 3.48% |
Novo Holdings A/S | 2,317,870 | $18,589,000 | 3.18% |
Copernicus Capital Management, LLC | 335,000 | $2,687,000 | 2.50% |
Boxer Capital, LLC | 2,325,000 | $18,647,000 | 1.35% |